Cite

HARVARD Citation

    Oh, T. et al. (n.d.). PI3K pathway inhibitors: potential prospects as adjuncts to vaccine immunotherapy for glioblastoma. Immunotherapy. pp. 737-753. [Online]. 
  
Back to record